Recall events
/
Event 77664
Event summary
Timeline bucket June 06, 2017
Product types Drug
Classifications Class I
Statuses Terminated
Recalling firm wording Andropharm, LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8
D-1142-2017
Recall number D-1142-2017
Initiated June 06, 2017
Classification Class I
Status Terminated
Quantity 150 bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Code information All lots remaining within expiry.
Distribution pattern Florida
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2244]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
ANDROPHARM M1 ALPHA (Methyl-1-Etiocholenolol-Epietiocholanollone 20 mg) capsule, packaged in 60-count bottle, Amazon.com, UPC 6 42125 50292 4
D-1143-2017
Recall number D-1143-2017
Initiated June 06, 2017
Classification Class I
Status Terminated
Quantity 1250 bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Code information All lots remaining within expiry.
Distribution pattern Florida
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3776]
FDA event record
· Exact recall-number query on openFDA